mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
palmostatin B |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.5 |
mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
0.034 |
0.5 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |